Skip to main content
Premium Trial:

Request an Annual Quote

Illumina, Bio-Rad Partner to Develop Single-Cell Genomics Workflow

NEW YORK (GenomeWeb) – Bio-Rad Laboratories and Illumina announced today an exclusive partnership to develop a comprehensive single-cell analysis workflow. Terms of the deal were not disclosed, but the companies anticipate a late 2016 or early 2017 launch.

The end-to-end commercial solution will enable high-throughput sequencing of thousands of individual cells, the companies said in a statement. The firms will combine Bio-Rad's droplet partitioning technology with Illumina's next-generation sequencing to isolate and barcode single cells, analyzing resulting data with Illumina's BaseSpace cloud infrastructure.

The scalable solution will isolate a larger number of single cells than current commercially available solutions in a few minutes and at a cost-effective price, according to the statement.

"We welcome the opportunity to collaborate with Illumina, the global leader in NGS technologies, to develop this long-awaited platform for single-cell genomics," Bio-Rad's Executive Vice President and General Manager of its Digital Biology Center, Annette Tumolo, said in a statement.

The collaboration enables both companies to serve "the significant market for single-cell NGS, enabling scientists to make groundbreaking advances in gene expression and beyond," noted Illumina Executive Vice President and Chief Commercial Officer Christian Henry. "Bio-Rad is recognized for delivering trusted, high-quality products in a market with increasingly stringent regulations and standards," he added.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.